main results : compared with a gastrointestinal disease control group ( 0.5 % +/- 0.8 % ) , specific lysis against ecac-c ( colon-derived ) among patients with inflammatory bowel disease was significantly greater in both multiply affected ( 8.4 % +/- 8.2 % ; p less than 0.01 ) and singly affected ( 5.2 % +/- 5.4 % ; p less than 0.05 ) families .
C0017178
gastrointestinal disease
C0021390
inflammatory bowel disease